Skip to main content

Table 4 Antifungal susceptibility profile of 179 oral yeast isolates from 851 healthy subjects from Kunming, China

From: Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China

Species (No.)

Antifungal agent

MIC range (μg/mL)

No. of S strains (%)a

No. of S-DD strains (%)b

No. of R strains (%)c

C. albicans (131)

Fluconazole

0.125-64

127 (96.9)

2 (1.5)

2 (1.5)

 

Itraconazole

0.031-16

121 (92.4)

2 (1.5)

8 (6.1)

 

Voriconazole

0.031-8

129 (98.5)

-

2 (1.5)

 

Amphotericin B

0.125-1

131 (100.0)

-

0 (0)

C. glabrata (17)

Fluconazole

0.25-64

15 (88.2)

0 (0)

2 (11.8)

 

Itraconazole

0.031-16

6 (35.3)

0 (0)

11 (64.7)

 

Voriconazole

0.031-8

16 (94.1)

 

1 (5.9)

 

Amphotericin B

0.5-1

17 (100.0)

-

0 (0)

C. krusei (3)

Fluconazole

4-64

2 (66.7)

0 (0)

1 (33.3)

 

Itraconazole

1-2

0 (0)

0 (0)

3 (100)

 

Voriconazole

0.125-2

2 (66.7)

-

1 (33.3)

 

Amphotericin B

0.5-1

3 (100.0)

-

0 (0)

C. tropicalis (4)

Fluconazole

0.25-4

4 (100.0)

0 (0)

0 (0)

 

Itraconazole

0.031-0.25

2 (50.0)

2 (50.0)

0 (0)

 

Voriconazole

0.031-0.063

4 (100.0)

-

0 (0)

 

Amphotericin B

0.5-1

4 (100.0)

-

0 (0)

C. parapsilosis (21)

Fluconazole

0.125-2

21 (100.0)

0 (0)

0 (0)

 

Itraconazole

0.031-0.25

13 (61.9)

8 (38.1)

0 (0)

 

Voriconazole

0.031-0.25

21 (100.0)

-

0 (0)

 

Amphotericin B

0.25-1

21 (100.0)

-

0 (0)

C. lusitaniae (1)

Fluconazole

0.25

1 (100.0)

0 (0)

0 (0)

 

Itraconazole

0.031

1 (100.0)

0 (0)

0 (0)

 

Voriconazole

0.031

1 (100.0)

-

0 (0)

 

Amphotericin B

1

1 (100.0)

-

0 (0)

C. guilliermondii (1)

Fluconazole

4

1 (100.0)

0 (0)

0 (0)

 

Itraconazole

0.5

0 (0)

1 (100.0)

0 (0)

 

Voriconazole

0.063

1 (100.0)

-

0 (0)

 

Amphotericin B

1

1 (100.0)

-

0 (0)

Pichia ohmeri (1)

Fluconazole

2

1 (100.0)

0 (0)

0 (0)

 

Itraconazole

2

0 (0)

0 (0)

1 (100)

 

Voriconazole

0.063

1 (100.0)

-

0 (0)

 

Amphotericin B

1

1 (100.0)

-

0 (0)

  1. a Susceptible (S) strains were defined by MIC ≤8 μg/mL for fluconazole, ≤0.125 μg/mL for itraconazole, <1 μg/mL for voriconazole and ≤ 1 μg/mL for amphotericin B.
  2. b Susceptible-dose dependent (S-DD) strains were defined by MICs between 16 μg/mL and 32 μg/mL for fluconazole and between 0.25 μg/mL and 0.5 μg/mL for itraconazole.
  3. c Resistant (R) strains were defined by MIC ≥64 μg/mL for fluconazole, ≥1 μg/mL for itraconazole and voriconazole, and >1 μg/mL for amphotericin B.